Advertisement

Topics

Shanghai ChemPartner Co., Ltd. Company Profile

22:00 EST 17th November 2017 | BioPortfolio

Founded in 2003, Shanghai ChemPartner Company Ltd. (ChemPartner) is one of the leading contract research organizations providing medicinal chemistry, discovery biology, pharmacology, DMPK, toxicology, process R&D, analytical development, formulation and contract manufacturing services to over 120 pharmaceutical and biotech companies in the world. ChemPartner currently has a team of over 1,000 scientists including over 90 senior scientific leaders with extensive industry experiences gained from leading global pharmaceutical and biotech companies.


News Articles [151 Associated News Articles listed on BioPortfolio]

M&As this week: Shanghai ChemPartner Co, Cell Medica, BBI Group Holding

ShangPharma Corporation's contract research subsidiary Shanghai ChemPartner Co Ltd is set to merge with Quantum Hi-Tech (China) Biological Co Ltd.

Dr. Lilly Xu Joins ChemPartner As Vice President And Head Of DMPK And Exploratory Toxicology

  Life Sciences Jobs   ...

Shanghai ChemPartner Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryShanghai ChemPartner Co Ltd ChemPartner, is a life science contract research organization. The organization offers services in the areas of chemistry, biology, biologics, drug metabolism pharma...

Ennovabio of Shanghai Raises $10 Million to Develop Brain Cancer Drug

Ennovabio, a Shanghai novel drug company, raised $10 million in a pre-A funding, led by HighLight Capital. Ennovabio is developing an innovative drug that targets brain glioma, while it also builds a ...

Buoyant biotech hub draws Merck KGaA to Shanghai

Shanghai’s flourishing biopharmaceuticals sector has attracted a major investment from Germany’s…

Shanghai Pharma signs deal with DHL to prepare for 'rapid global expansion'

Shanghai Pharmaceuticals, one of China’s largest listed pharma groups, has signed a memorandum of understanding…

Shanghai Pharma bids for U.S. Cardinal Health's China business

By Julie Zhu HONG KONG (Reuters) - Shanghai Pharmaceuticals Holding Co has bid for Cardinal Health Inc's China business as the U.S. company looks to sell ahead of China's planned drug distribution r...

Shanghai Pharma Acquires Cardinal's China Drug Distribution Business for $1.2 Billion

Shanghai Pharma paid $1.2 billion to win the bidding war for Cardinal Health's China drug distribution operations. Cardinal was China's eighth-largest drug distribution company, with $3.5 billion in 2...

PubMed Articles [74 Associated PubMed Articles listed on BioPortfolio]

Hexabromocyclododecane and tetrabromobisphenol A in tree bark from different functional areas of Shanghai, China: levels and spatial distributions.

The concentrations and spatial distributions of hexabromocyclododecane (HBCDD) and tetrabromobisphenol A (TBBPA) were measured in tree bark from different functional areas of Shanghai. ΣHBCDD (sum of...

Comparison of air pollution in Shanghai and Lanzhou based on wavelet transform.

For a long-period comparative analysis of air pollution in coastal and inland cities, we analyzed the continuous Morlet wavelet transform on the time series of a 5274-day air pollution index in Shangh...

Incident rate and Risk Factors for Tuberculosis among Patients with Type 2 Diabetes: Retrospective Cohort Study in Shanghai, China.

To examine the incident rate of tuberculosis (TB) and its associates among adults with type 2 diabetes in Shanghai, China.

Comparison of PM2.5 carbonaceous pollutants between an urban site in Shanghai and a background site in a coastal East China Sea island in summer: concentration, composition and sources.

Nine paired samples of atmospheric particulate matter with an aerodynamic diameter less than or equal to 2.5 μm (PM2.5) were collected concurrently from an urban site in Shanghai, China and a backgro...

Economic Impacts from PM2.5 Pollution-Related Health Effect: A Case Study in Shanghai.

PM2.5 pollution-related diseases cause additional medical expenses and work time loss, leading to macroeconomic impact in high PM2.5 concentration areas. Previous economic impact assessments of air po...

Clinical Trials [43 Associated Clinical Trials listed on BioPortfolio]

Shanghai Epidemiology Study for Adolescents and Children With Cancer

The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002.

Progression of Hematopoietic Diseases in Shanghai, China

The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular ch...

Systemic Redesign and Demonstration for Early Detection, Evaluation and Management of Chronic Kidney Disease in Shanghai

Based on clinical evidence based medicine and organizational management model, investigators redesign the prevention and treatment of chronic kidney disease of public health system in Shan...

H7N9 Mix and Match With AS03 and MF59 in Healthy Adults

This Phase II randomized, double-blinded, controlled study in up to 1000 males and non-pregnant females, 19 to 64 years old, inclusive, who are in good health and meet all eligibility crit...

A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women

A prospective cohort study is proposed to evaluate occupational and environmental risk factors for cancer among women in Shanghai, China. Approximately 75,000 women aged 40-69 who reside ...

Companies [113 Associated Companies listed on BioPortfolio]

Shanghai ChemPartner

Founded in 2003, Shanghai ChemPartner (ChemPartner) is one of the leading contract research organizations providing medicinal chemistry, discovery biology, pharmacology, DMPK, toxicology, process ...

Shanghai ChemPartner Co., Ltd.

Founded in 2003, Shanghai ChemPartner Company Ltd. (ChemPartner) is one of the leading contract research organizations providing medicinal chemistry, discovery biology, pharmacology, DMPK, toxicol...

LEAD Therapeutics, Inc.

LEAD Therapeutics began operations in April 2007 as a drug discovery company. LEAD has offices in San Bruno, California, and in Shanghai, China. Drug discovery programs are conduc...

Shanghai Sun Island International Club

Nestled upstream of the Huangpu river that flows to the Shanghai Bund, Shanghai Sun Island is a 160 hectares island resort. Sun Island presents a simple yet sophisticated style that transcends the cos...

Shanghai Medical Technology Co., Ltd.

Shanghai Medical is a leading provider of Hemodialysis and renal care equipment, supplies, and related support services in Eastern China. Specifically, Shanghai Medical distributes and sells Hemod...

More Information about "Shanghai ChemPartner Co., Ltd." on BioPortfolio

We have published hundreds of Shanghai ChemPartner Co., Ltd. news stories on BioPortfolio along with dozens of Shanghai ChemPartner Co., Ltd. Clinical Trials and PubMed Articles about Shanghai ChemPartner Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Shanghai ChemPartner Co., Ltd. Companies in our database. You can also find out about relevant Shanghai ChemPartner Co., Ltd. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record